Vy Spine has received FDA clearance for its VySion-P SI Fusion and VyStop SI Screw Systems, designed to treat sacroiliac joint conditions, including degenerative sacroiliitis and joint disruptions.
The VySion-P system is intended for sacroiliac joint fusion and stabilization in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion. The implant must be used alongside the VyStop SI Screw System to create a hybrid fusion construct, according to a Nov. 17 news release.
The VyStop system is also cleared for sacroiliac joint dysfunction associated with degenerative sacroiliitis or joint disruption, as well as acute, non-acute and non-traumatic fractures involving the joint.
VySion-P is the first polymeric device of its kind cleared for sacroiliac fusion and the first SI fusion device incorporating the company’s 3D-printed OsteoVy PEKK material, according to Vy Spine. The implant also features self-drilling screws designed to anchor it directly to bone.
